ストックスクリーナーアプリを入手
13.15
1.87%
-0.25
前日終値:
$13.40
開ける：
$13.32
24時間の取引高:
283.72K
Relative Volume:
0.70
時価総額：
$447.60M
収益：
$2.07M
当期純損益:
$-47.68M
株価収益率:
-4.6631
EPS:
-2.82
ネットキャッシュフロー:
$-31.31M
1週間 パフォーマンス:
-4.15%
1か月 パフォーマンス:
-5.73%
6か月 パフォーマンス:
+43.95%
1年 パフォーマンス:
+175.68%
1日の値動き範囲:
$12.92
$13.57
1週間の範囲:
$12.92
$14.61
52週間の値動き範囲:
$4.26
$16.97
Delcath Systems Inc Stock (DCTH) Company Profile
名前
Delcath Systems Inc
セクター
電話
(518) 743-8892
住所
566 QUEENSBURY AVENUE, QUEENSBURY, NY
DCTH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DCTH
Delcath Systems Inc
|
13.15 | 447.60M | 2.07M | -47.68M | -31.31M | -2.82 |
|
ABT
Abbott Laboratories
|
130.82 | 226.88B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
99.36 | 146.96B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
364.50 | 142.81B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
87.63 | 112.37B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.91 | 41.85B | 5.72B | 4.17B | 259.90M | 6.97 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-06-28 | 開始されました | Craig Hallum | Buy |
| 2024-05-14 | 開始されました | Stephens | Overweight |
| 2022-07-26 | 再開されました | Canaccord Genuity | Buy |
| 2021-12-10 | 開始されました | H.C. Wainwright | Buy |
| 2021-03-09 | 開始されました | Canaccord Genuity | Buy |
| 2021-01-05 | 開始されました | BTIG Research | Buy |
| 2020-06-01 | 開始されました | Laidlaw | Buy |
すべてを表示
Delcath Systems Inc (DCTH) 最新ニュース
Beta Bionics appoints new board member from Delcath Systems By Investing.com - Investing.com South Africa
Beta Bionics appoints new board member from Delcath Systems - Investing.com India
Beta Bionics Announces Board Appointment of Gerard Michel - TradingView
Jim Cramer Blesses Delcath Systems (DCTH): ‘You’re Not Early, But It’s a Win’ - MSN
Jim Cramer Discussed These 6 Stocks Recently - Insider Monkey
Wall Street Analysts See a 58.49% Upside in Delcath Systems (DCTH): Can the Stock Really Move This High? - MSN
Delcath Systems to Participate at the Canaccord Genuity Horizons in Oncology Virtual Conference - Lelezard
Liver Cancer Treatment Breakthrough? Delcath to Reveal Latest Advances at Major Oncology Conference - StockTitan
Is aTyr Pharma (ATYR) Stock Outpacing Its Medical Peers This Year? - Nasdaq
Delcath Systems, Inc. (NASDAQ:DCTH) Q4 2024 Earnings Call Transcript - MSN
Delcath Systems awards stock options to new employees By Investing.com - Investing.com Australia
Delcath Systems awards stock options to new employees - Investing.com India
Delcath Systems Strengthens Workforce: 264,000 Stock Options Granted to New Strategic Hires - StockTitan
Delcath Systems Reports Strong 2024 Financial Growth - TipRanks
With A 27% Price Drop For Delcath Systems, Inc. (NASDAQ:DCTH) You'll Still Get What You Pay For - Simply Wall St
Delcath Systems’ Earnings Call Highlights Strong Growth and Strategic Expansion - TipRanks
Delcath Systems (NASDAQ:DCTH) Price Target Raised to $24.00 - Defense World
HC Wainwright Estimates Delcath Systems FY2029 Earnings - Defense World
Delcath Systems, Inc. (DCTH) Beats Q4 Earnings and Revenue Estimates - MSN
Earnings Beat: Delcath Systems, Inc. (NASDAQ:DCTH) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts - Yahoo Finance
Private Advisor Group LLC Acquires New Position in Delcath Systems, Inc. (NASDAQ:DCTH) - Defense World
Positive Outlook for Delcath Systems: Promising Growth and Strategic Expansion Drive Buy Rating - TipRanks
Delcath stock price target raised to $24 by H.C. Wainwright - Investing.com India
Strong Growth Potential for Delcath Systems: Buy Rating Affirmed with Raised Price Target - TipRanks
Delcath Systems reports net loss of USD 3.4M in Q4 2024 - Medical Buyer
Here's Why We're Not Too Worried About Delcath Systems' (NASDAQ:DCTH) Cash Burn Situation - Yahoo Finance
Delcath Systems Inc (DCTH) Q4 2024 Earnings Call Highlights: Strong HEPZATO Revenue and ... - Yahoo Finance
Delcath Systems Braces for Financial Impact Amid Uncertain Tax Law Changes - TipRanks
BTIG lifts Delcath Systems stock target to $22, maintains buy By Investing.com - Investing.com Canada
BTIG lifts Delcath Systems stock target to $22, maintains buy - Investing.com
Delcath Systems reports Q4 EPS (11c), consensus 1c - TipRanks
Delcath Systems Inc reports results for the quarter ended December 31Earnings Summary - TradingView
DELCATH SYSTEMS, INC. SEC 10-K Report - TradingView
Earnings call transcript: Delcath Systems Q4 2024 results show mixed performance - Investing.com
Delcath Systems Inc (DCTH) Q4 Earnings: Revenue Surpasses Estima - GuruFocus.com
Delcath Systems Inc. Q4 Loss Decreases, But Misses Estimates - Nasdaq
Can Delcath's 30x Revenue Growth and FDA Trial Approval Transform Cancer Treatment? - StockTitan
Delcath Systems, Inc. (NASDAQ:DCTH) Shares Acquired by Principal Financial Group Inc. - Defense World
Carcinoid Tumor Treatment Market Size in the 7MM is expected - openPR
Delcath Systems Inc expected to post a loss of 2 cents a shareEarnings Preview - TradingView
(DCTH) Proactive Strategies - Stock Traders Daily
The future of U.S. medical devices companies amid tariff impositions (IHI:NYSEARCA) - Seeking Alpha
Is Corcept Therapeutics (CORT) Outperforming Other Medical Stocks This Year? - Yahoo Canada Finance
Delcath Systems (DCTH) Expected to Announce Earnings on Thursday - Defense World
Painful week for retail investors invested in Delcath Systems, Inc. (NASDAQ:DCTH) after 14% drop, institutions also suffered losses - Simply Wall St
Where are the Opportunities in (DCTH) - Stock Traders Daily
Delcath Systems Inc (DCTH) 財務データ
収益
当期純利益
現金流量
EPS
0.55%
0.10%
大文字化:
|
ボリューム (24 時間):